Dolby Laboratories Inc-cl A (DLB) — Institutional Investor Activity (Q2 2026)

DLB ranks #1575 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

390 institutions disclose a position in DLB, but none treat it as a major bet — even Shapiro Capital Management LLC, its most concentrated holder, allocates just 1.2% of its own portfolio to it.

Fidelity has added to its DLB position for two straight quarters, increasing it by $82.3M to reach $83.4M today.

Morgan Stanley has trimmed its DLB position for two straight quarters, cutting it by $154.4M while still holding $242.0M.

DLB is up 0.6% today, and institutions have been net buyers of $431.2M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

DLB posted net income of $226.2M over the trailing twelve months, and currently trades at a P/E of 26.6.

• Profitable — net income of $226.2M over the trailing twelve months
• Revenue grew 2.6% year over year
• Net income declined year over year, from $256.6M to $226.2M
• Generated $472.2M in positive operating cash flow
• Current ratio of 3.17x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.23x equity — within a conventional range